Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$814M |
| 2 |
NVIDIA
NVDA
|
+$448M |
| 3 |
Microsoft
MSFT
|
+$394M |
| 4 |
Apple
AAPL
|
+$368M |
| 5 |
Johnson & Johnson
JNJ
|
+$288M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$616M |
| 2 |
Tesla
TSLA
|
+$406M |
| 3 |
Palo Alto Networks
PANW
|
+$400M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$394M |
| 5 |
AT&T
T
|
+$389M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.96% |
| 2 | Technology | 19.64% |
| 3 | Consumer Staples | 10.59% |
| 4 | Consumer Discretionary | 10.5% |
| 5 | Communication Services | 8.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ONCS
2626
DELISTED
OncoSec Medical Incorporated
ONCS
| $1.1M | ﹤0.01% |
17,796
+2,309
| +15% | +$210K |
|
2627
MBIA
MBI
$261M
| $1.1M | ﹤0.01% |
99,674
-27,800
| -22% | -$277K |
|
2628
Sinclair Inc
SBGI
$992M
| $1.09M | ﹤0.01% |
+32,971
| New | +$1.07M |
|
2629
Oak Valley Bancorp
OVLY
$285M
| $1.09M | ﹤0.01% |
60,073
+31,009
| +107% | +$552K |
|
|
YARW
2630
Yarrow Bioscience, Inc. Common Stock
YARW
$23.4M
| $1.09M | ﹤0.01% |
+345
| New | +$1.37M |
|
2631
Astec Industries
ASTE
$1.16B
| $1.08M | ﹤0.01% |
17,245
+9,800
| +132% | +$684K |
|
2632
Brookfield Infrastructure
BIPC
$5.2B
| $1.08M | ﹤0.01% |
21,450
+2,100
| +11% | +$101K |
|
|
SSY
2633
DELISTED
SunLink Health Systems
SSY
| $1.07M | ﹤0.01% |
312,384
-3,300
| -1% | -$9.38K |
|
|
TULP
2634
Bloomia Holdings
TULP
| $1.06M | ﹤0.01% |
128,409
-17,800
| -12% | -$118K |
|
2635
iShares MSCI France ETF
EWQ
$335M
| $1.06M | ﹤0.01% |
28,100
-2,300
| -8% | -$87K |
|
|
ASRT
2636
DELISTED
Assertio
ASRT
| $1.06M | ﹤0.01% |
45,439
-19,972
| -31% | -$576K |
|
|
MYND
2637
Mynd.ai
MYND
$18M
| $1.06M | ﹤0.01% |
24,391
-6,400
| -21% | -$221K |
|
2638
Schwab International Equity ETF
SCHF
$66.6B
| $1.06M | ﹤0.01% |
53,800
-204,200
| -79% | -$4.04M |
|
2639
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.7B
| $1.06M | ﹤0.01% |
13,100
-4,400
| -25% | -$353K |
|
2640
Cytosorbents Corp
CTSO
$22.7M
| $1.06M | ﹤0.01% |
140,100
-39,900
| -22% | -$336K |
|
2641
MVB Financial
MVBF
$397M
| $1.06M | ﹤0.01% |
24,800
-41,300
| -62% | -$1.69M |
|
|
ETTX
2642
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
| $1.05M | ﹤0.01% |
391,629
-394,977
| -50% | -$892K |
|
2643
Origin Bancorp
OBK
$1.69B
| $1.04M | ﹤0.01% |
24,600
-20,400
| -45% | -$885K |
|
2644
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$11.5B
| $1.04M | ﹤0.01% |
+28,400
| New | +$1.04M |
|
2645
Plexus
PLXS
$6.72B
| $1.04M | ﹤0.01% |
11,393
+6,800
| +148% | +$637K |
|
2646
i3 Verticals
IIIV
$412M
| $1.03M | ﹤0.01% |
+34,200
| New | +$1.08M |
|
|
BIOL
2647
DELISTED
Biolase, Inc.
BIOL
| $1.03M | ﹤0.01% |
593
-296
| -33% | -$549K |
|
2648
ZW Data Action Technologies
CNET
$5.87M
| $1.03M | ﹤0.01% |
25,828
+21,168
| +454% | +$816K |
|
2649
Invesco Mortgage Capital
IVR
$759M
| $1.03M | ﹤0.01% |
26,479
-70,003
| -73% | -$2.65M |
|
|
SYBX
2650
DELISTED
Synlogic
SYBX
| $1.03M | ﹤0.01% |
17,606
-3,303
| -16% | -$180K |
|
Similar funds
Renaissance Technologies's Q2 2021 Portfolio in Review
As of Q2 2021, Renaissance Technologies held 3,960 positions worth $80.1B, down 0.34% from $80.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $5.63B in Q2 2021, closing 551 positions and reducing 1,699 holdings. Its most notable exit was AT&T, an estimated $389M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Caterpillar worth $227M.
- Renaissance Technologies's largest Q2 2021 buy was Caterpillar: 1,042,778 shares worth $227M.
- Renaissance Technologies added most to Amazon in Q2 2021, an estimated $814M increase.
- Renaissance Technologies's biggest Q2 2021 reduction was Baidu, cutting an estimated $616M.
- Renaissance Technologies fully exited AT&T in Q2 2021, selling an estimated $389M.
- Renaissance Technologies's ten largest holdings make up 12% of its $80.1B portfolio in Q2 2021.
- Renaissance Technologies opened 701 new positions and closed 551 in Q2 2021.
- Renaissance Technologies's portfolio value fell 0.34% quarter-over-quarter to $80.1B.
Based on Renaissance Technologies's 13F filing for Q2 2021, filed 13 Aug 2021.